Author Topic: (Abst.) COVID-19 and MS disease-modifying therapies  (Read 80 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From NEJM Journal Watch (May 12, 2020)--"Tocilizumab might attenuate 'cytokine storm' in some COVID-19 in some patients":


https://www.jwatch.org/na51506/2020/05/12/tocilizumab-might-attenuate-cytokine-storm-covid-19?query=C19
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
78 Views
Last post June 05, 2016, 02:24:56 pm
by agate
0 Replies
99 Views
Last post March 12, 2017, 03:20:29 pm
by agate
0 Replies
109 Views
Last post May 16, 2017, 11:42:43 am
by agate
0 Replies
112 Views
Last post September 26, 2017, 03:41:45 pm
by agate
0 Replies
4 Views
Last post January 30, 2024, 04:14:39 pm
by agate